市場調查報告書

沙烏地阿拉伯的醫藥品包裝市場:成長,趨勢,預測(2020年∼2025年)

Saudi Arabia Pharmaceutical Packaging Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 922595
出版日期 內容資訊 英文 125 Pages
商品交期: 2-3個工作天內
價格
沙烏地阿拉伯的醫藥品包裝市場:成長,趨勢,預測(2020年∼2025年) Saudi Arabia Pharmaceutical Packaging Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 125 Pages
簡介

沙烏地阿拉伯作為沿岸地區的醫藥品一大市場,為了解除醫藥品不足的問題,致力於糖尿病和高血壓的治療藥等醫藥品的國內生產,提高現在停留在30%左右的當地生產的比率,也擴大醫藥品包裝製造商的商機。還有人口和人力資源的增加伴隨的醫療支出的增加,生活方式的變化等要素也成為推動力。國內醫藥品包裝市場,預測將從2019年的12億9,343萬美元擴大到2025年21億3,641萬美元,在2020年∼2025年間預測年複合成長率將為7.51%。

本報告提供沙烏地阿拉伯的醫藥品包裝市場調查,市場力學,各材料,各種類的分析,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查的成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場力學

  • 市場概要
  • 簡介
  • 成長促進因素
    • 變得嚴重的健康問題
    • 促進醫藥品包裝市場成長的技術的進步
  • 成長阻礙因素
    • 以醫藥品包裝的原料為中心的環境方面的問題
  • 產業的價值鏈分析
  • 產業的魅力:-波特的五力分析
    • 新加入廠商勢力的威脅
    • 買主談判力
    • 供應商談判力
    • 替代產品的威脅
    • 競爭加劇

第5章 市場區隔

  • 各材料
    • 塑膠
    • 紙,紙板
    • 玻璃
    • 鋁箔
    • 其他
  • 各類型
    • 安瓿
    • 保護蓋,封
    • 濾芯
    • IV(點滴)袋子
    • 罐子
    • 投藥用管
    • 管瓶
    • 注射器
    • 帶包裝,泡殼包裝
    • 小袋
    • 小袋

第6章 競爭情形

  • 企業簡介
    • CCL Industries
    • Napco Group
    • Becton, Dickinson and Company
    • Rexam PLC (Ball Corporation)
    • Sealed Air Saudi Arabia
    • Sealed Air Saudi Arabia
    • Salman Group (Noor Carton & Packaging Industry)
    • Jabil Inc.
    • Aptar Group
    • Amber Packaging Industries LLC

第7章 投資展望

第8章 市場機會及今後趨勢

目錄
Product Code: 53452

Market Overview

The Saudi Arabia Pharmaceutical Packaging market was valued at USD 1293.43 million in 2019 and is expected to reach USD 2136.41 million by 2025, at a CAGR of 7.51% over the forecast period 2020 - 2025. According to Export.gov, the Kingdom of Saudi Arabia accounts for 59.4 % of the purchases of pharmaceuticals products in the Gulf region. Thus, it has a positive impact on Saudi Arabia Pharmaceutical Packaging Market.

  • Further, Saudi Arabia's Vision 2030 and the National Transformation Program (NTP)'s identified the Industrial Clusters (IC) as the lead government entity to develop five industrial sectors including the pharmaceutical and biotech industry. Additionally, only 30% of pharmaceutical products are manufactured locally. Therefore, opportunities for pharmaceutical packaging manufacturers is expected to grow significantly.
  • Moreover, according to the National Center for Biotechnology Information, there is a shortage of drugs in Saudi Arabia, which is negatively impacting the health of common public, and this problem is recurring from the last decades. To understand the root cause and overcome this issue, in 2018, the Pharmacy Education Unit at King Saud University College of Pharmacy has called for a meeting with multiple stakeholders. Thus, to improve the condition in the region, they are working towards the localization of the pharmaceutical industry. For instance, in 2018, Saudi Arabian General Investment Authority (SAGIA), through its joint cooperation with international pharmaceutical companies signed an agreement between Novartis and AJA Pharma, so as to manufacture pharmaceutical products to treat diabetes and blood pressure.
  • However, different government regulations are expected to hinder the growth of plastic bottles in the country, further affecting the overall bottle packaging in the pharmaceutical industry in the state.

Scope of the Report

Pharmaceutical packaging is used for the packing of pharmaceutical products to secure them from any external harmful toxins and rays. The rising population and with the increasing workforce, the increase in per capita spending on health care services is also growing in the region. Thus, the busy schedule and changing lifestyle will lead to increasing consumers' adoption of easy-to-swallow medicines, leading to the growth in demand for the powdered and liquid form of medicine. This will create a demand for different packaging types such as pouches, and sachets. In return, it will also act as a catalyst for the Saudi Arabia pharmaceutical packaging market.

Key Market Trends

Pharmacy Model for Vision 2030 to Drive the Market Growth

  • With this new vision, the government decided to privatize all its public hospitals and introduce Public-Private Partnership programs, as included in the government's NTP 2020 objectives. Some of those objectives are to increase the number of licensed medical facilities from 40 to 100 and double the number of primary care centers visits per capita from two to four.
  • Further, the Ministry of Health (MOH) plans to privatize all its services through the National Transformation Program 2020 which will increase the private sector contribution to the health sector from 25-35%. The public sector dominates the supply of healthcare services in Saudi Arabia and accounts for the majority of healthcare expenditures. But the government policies are encouraging more private sector than public sector involvement in the provision of healthcare services.
  • Moreover, the project 'Domestic production' to contribute 40% of the market by 2020 in line with the National Transformation program objectives to localize the industry.
  • Such initiatives will increase the sales of pharmaceutical products in the region, which in return will increase the demand for the pharmaceutical packaging market.

Increase in Diabetic Patients is Expected to Boost the Market in the Country

  • Non-communicable diseases such as diabetes, cardiovascular disease, and cancer have become the leading cause of death among Saudi Arabia population. This is due to a sedentary lifestyle, obesity, high tobacco use, and poor dietary choices. The World Health Organization (WHO) figures indicate that 33.7% of Saudi Arabia adults are obese, and 68.2% are overweight.
  • Moreover, the number of diabetics in the country has also increased recently. Owing to this, government initiatives are driving the usage of healthcare products and services.
  • In support to this, as the government policies in the country are biased in favor of domestic producers, providing them with exemptions, including interest-free funding, subsidized utility charges, and no import duties on raw materials and intermediate products, the increased demand for the cures for diseases such as diabetes are expected to create a significant demand for packaging in the country.

Competitive Landscape

The Saudi Arabia pharmaceutical packaging market is moderately fragmented, and competition among the players is increasing. Additionally, because of the concept of 'Domestic production' in the region and 'Saudi 2030 Vision', many players are entering this market. Product launches, high expense on research and development, partnerships and acquisitions, etc. are the prime growth strategies adopted by the companies to gain competitive advantages. Some of the recent developments are:

  • June 2019 - Jabil Packaging Solutions introduced a new suite of Sustainable Packaging Services, that enable packaged goods brands to design and deliver innovative new sustainable packaging formats into the marketplace at speed. As a custom packaging solutions provider with a rich history of transformational brand equity packaging, the company has uniquely positioned itself to work intimately with brands to solve their challenges at a rapid pace, thereby reducing complexity and mitigating risks.
  • March 2019 - Saudi Basic Industries Corporation introduced its COHERE S-series, produced using NEXLENE technology. It was developed in response to market demand for solutions with more effective sealing properties to protect its contents better, and properties to allow higher production efficiency in the flexible packaging industry. This will potentially support the reduction of waste and cost savings.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Introduction to Market Drivers and Restraints
  • 4.3 Market Drivers
    • 4.3.1 Growing Health Concerns in the Country
    • 4.3.2 Technological Advancements to Contribute to the Growth of Pharmaceutical Packaging
  • 4.4 Market Restraints
    • 4.4.1 Environmental Concerns Related to Pharmaceutical Packaging Raw Materials
  • 4.5 Industry Value Chain Analysis
  • 4.6 Industry Attractiveness - Porter's Five Force Analysis
    • 4.6.1 Threat of New Entrants
    • 4.6.2 Bargaining Power of Buyers/Consumers
    • 4.6.3 Bargaining Power of Suppliers
    • 4.6.4 Threat of Substitute Products
    • 4.6.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Material
    • 5.1.1 Plastic
    • 5.1.2 Paper & Paperboard
    • 5.1.3 Glass
    • 5.1.4 Aluminum Foil
    • 5.1.5 Others
  • 5.2 By Type
    • 5.2.1 Bottles
    • 5.2.2 Ampoules
    • 5.2.3 Caps and Closures
    • 5.2.4 Cartridges
    • 5.2.5 IV (Intravenous) Bags
    • 5.2.6 Canisters
    • 5.2.7 Medication Tubes
    • 5.2.8 Vials
    • 5.2.9 Syringes
    • 5.2.10 Strip and Blister Packs
    • 5.2.11 Pouches
    • 5.2.12 Sachets

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 CCL Industries
    • 6.1.2 Napco Group
    • 6.1.3 Becton, Dickinson and Company
    • 6.1.4 Rexam PLC (Ball Corporation)
    • 6.1.5 Sealed Air Saudi Arabia
    • 6.1.6 Sealed Air Saudi Arabia
    • 6.1.7 Salman Group (Noor Carton & Packaging Industry)
    • 6.1.8 Jabil Inc.
    • 6.1.9 Aptar Group
    • 6.1.10 Amber Packaging Industries LLC

7 INVESTMENT OUTLOOK

8 MARKET OPPORTUNITIES AND FUTURE TRENDS